Detalles de la búsqueda
1.
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice.
Cell
; 134(4): 577-86, 2008 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-18691745
2.
Chip-based platform for dynamic analysis of NK cell cytolysis mediated by a triplebody.
Analyst
; 141(7): 2284-95, 2016 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26958659
3.
NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2.
J Transl Med
; 11: 289, 2013 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24237598
4.
A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells.
J Immunol
; 184(3): 1210-7, 2010 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20042573
5.
Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo.
Mol Cancer
; 9: 301, 2010 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-21092273
6.
Novel conjugates of single-chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells.
Br J Haematol
; 148(6): 879-89, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20064159
7.
A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting.
Br J Haematol
; 150(5): 574-86, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20636437
8.
A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells.
Melanoma Res
; 18(2): 73-84, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18337643
9.
Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells.
Oncoimmunology
; 7(9): e1472195, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30228941
10.
Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7.
Cancer Res
; 65(8): 3380-8, 2005 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15833872
11.
A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cells.
Cancer Res
; 62(10): 2848-55, 2002 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12019163
12.
Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19+ CD33+ leukemia cells.
Oncotarget
; 7(16): 22579-89, 2016 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26981773
13.
CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells.
Oncotarget
; 7(50): 83392-83408, 2016 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27825135
14.
Efficient eukaryotic expression of fluorescent scFv fusion proteins directed against CD antigens for FACS applications.
J Immunol Methods
; 285(2): 265-80, 2004 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14980440
15.
A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cells.
MAbs
; 6(1): 286-96, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24135631
16.
T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell.
Oncotarget
; 5(15): 6466-83, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25115385
17.
A recombinant triplebody with specificity for CD19 and HLA-DR mediates preferential binding to antigen double-positive cells by dual-targeting.
MAbs
; 4(1): 45-56, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22327429
18.
Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cells.
Cancer Lett
; 303(2): 128-39, 2011 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-21339041
19.
A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting.
MAbs
; 3(1): 21-30, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21081841
20.
Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.
J Immunol Methods
; 373(1-2): 67-78, 2011 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-21855548